Recursion Pharmaceuticals (RXRX) CFO covers RSU taxes with 48,028 shares

Rhea-AI Filing Summary

Recursion Pharmaceuticals CFO Ben R. Taylor reported a tax-related share disposition. On April 6, 2026, 48,028 shares of Class A Common Stock at $3.11 per share were withheld by the company to cover tax obligations from net settlement of restricted stock units. After this withholding, Taylor directly owns 1,132,290 shares of the company’s Class A Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Taylor Ben R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock	48,028	$3.11	$149K

Holdings After Transaction: Class A Common Stock — 1,132,290 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 48,028 shares Transaction price per share: $3.11 per share Shares held after transaction: 1,132,290 shares

3 metrics

Shares withheld for taxes 48,028 shares Withheld to satisfy tax obligations on RSU net settlement

Transaction price per share $3.11 per share Value applied to withheld Class A Common Stock

Shares held after transaction 1,132,290 shares CFO’s direct ownership of Class A Common Stock after withholding

Key Terms

restricted stock units, tax withholding, net settlement, Class A Common Stock

4 terms

restricted stock units financial

"in connection with the net settlement of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding financial

"withheld by the Issuer to satisfy its tax withholding and remittance obligations"

Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.

net settlement financial

"in connection with the net settlement of restricted stock units"

Class A Common Stock financial

"Represents shares that have been withheld by the Issuer"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Ben R

(Last) (First) (Middle)

41 S. RIO GRANDE STREET

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/06/2026		F(1)		48,028	D	$3.11	1,132,290	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

Remarks:

	/s/Jonathan Golightly, attorney-in-fact	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did RXRX CFO Ben Taylor report in this Form 4 filing?

RXRX CFO Ben R. Taylor reported a tax-related share disposition. The company withheld 48,028 shares of Class A Common Stock to satisfy tax obligations arising from the net settlement of restricted stock units granted to him.

How many RXRX shares were withheld for taxes from the CFO’s RSUs?

A total of 48,028 shares of Recursion Pharmaceuticals Class A Common Stock were withheld. These shares covered tax withholding and remittance obligations linked to the net settlement of restricted stock units previously awarded to CFO Ben R. Taylor.

Does this RXRX Form 4 show an open-market sale by the CFO?

No, the Form 4 does not show an open-market sale. The 48,028 shares were withheld by Recursion Pharmaceuticals to meet tax withholding requirements on restricted stock units, rather than being sold in the open market by the CFO.

How many RXRX shares does the CFO hold after this tax withholding?

Following the tax withholding, CFO Ben R. Taylor directly holds 1,132,290 shares of Recursion Pharmaceuticals Class A Common Stock. This figure reflects his post-transaction ownership position reported in the Form 4 filing with the Securities and Exchange Commission.

What is the reported price per RXRX share in this Form 4 transaction?

The Form 4 reports a transaction price of $3.11 per share for the 48,028 withheld shares. This price is used to determine the value of shares applied toward satisfying the issuer’s tax withholding and remittance obligations on the restricted stock units.